Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
1-15 March 2007  
Untitled Document
Sections

Market
Management
Research
Pharma Life
 Healthcare

Services
Open Forum
Subscribe/Renew
Archives
Contact Us
Network Sites
Express Computer
Network Magazine India
Express Channel Business
Express Hospitality
Express TravelWorld
feBusiness Traveller
Exp. Healthcare Mgmt.
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express



Home - Market - Article

Company Watch

Lupin receives USFDA approval for Sertraline

Our News Bureau - Mumbai

Lupin announced that the USFDA has approved the company's Abbreviated New Drug Application (ANDA) for Sertraline Hydrochloride Tablets, 25 mg, 50 mg and 100 mg. Sertraline Hydrochloride is indicated for the treatment of major depressive disorder. Lupin's Sertraline Tablets are the AB-rated generic equivalent of Pfizer's Zoloft Tablets. The branded product had annual sales of approximately $2.1 billion for the 12-month period ended December 2006, according to IMS Health. With this approval, Lupin now has 18 ANDAs approved by the USFDA.

 


Untitled Document
Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.